Showing 2771-2780 of 4162 results for "".
- Art Lesson Teaches Plastic Surgeons Better Botox Injection Techniqueshttps://modernaesthetics.com/news/art-lesson-teaches-plastic-surgeons-better-botox-injection-techniques-facebookshare-to/2472207/A highly detailed body painting project helps plastic surgeons understand how underlying muscles contribute to facial lines and wrinkles as well as how to better treat them using botulinum toxin injections. The illustrated article, which appears in Plas
- Syneron Candela Becomes Private Company with Completion of Transaction with Funds Advised by Apax Partnershttps://modernaesthetics.com/news/syneron-candela-becomes-private-company-with-completion-of-transaction-with-funds-advised-by-apax-partners/2472211/Syneron Medical Ltd. announced the successful completion of its acquisition by an affiliate of funds advised by Apax Partners for $11.00 per share in cash in a transaction valued at approximately $400 million. The transacti
- USA, Brazil Take the Lead for Most Plastic Surgery Procedureshttps://modernaesthetics.com/news/usa-brazil-take-the-lead-for-most-plastic-surgery-procedures/2472215/Plastic surgery is on the rise across the globe, according to new statistics from The International Society of Aesthetic Plastic Surgery (ISAPS). There was an overall increase of 9 percent in surgical and non-surgical cosmetic procedures in 2016.
- ASDS: Seven of 10 Consumers Considering Nips or Tuckshttps://modernaesthetics.com/news/asds-seven-of-10-consumers-considering-plastic-surgery/2472214/Nearly 70 percent of consumers now say they are thinking about getting a cosmetic treatment, according to survey data released by the American Society for Dermatologic Surgery (ASDS). The ASD
- NJ Plastic Surgeon Dr. Barry Dibernardo To Lead ASERFhttps://modernaesthetics.com/news/nj-plastic-surgeon-barry-dibernardo-md-to-lead-aserf/2472233/New Jersey-based plastic surgeon Barry Dibernardo, MD is the new President of the Aesthetic Surgery Education And Research Foundation. ASERF is the philanthropic research and education arm of the American Society fo
- Plastic Surgeons Offer Video Tips To Maximize Safety During Filler Injectionshttps://modernaesthetics.com/news/plastic-surgeons-offer-tips-to-maximize-safety-during-filler-injections/2472236/Avoiding key "danger zones" may help plastic surgeons enhance the safety and effectiveness of facial filler procedures, according to an expert update in the May issue of Plastic and Reconstructive Surgery®. The article out
- ASPS: More than $16 Billion Spent on Cosmetic Plastic Surgery in 2016https://modernaesthetics.com/news/asps-more-than-16-billion-spent-on-cosmetic-plastic-surgery-in-2016/2472246/Americans spent more than ever before – $16 billion – on cosmetic plastic surgery and minimally-invasive procedures in 2016, according to a new report from the American Society of Plastic Surgeons (ASPS). The new report also breaks
- Restylane® Refyne and Restylane® Defyne Show Lasting Natural Benefit in Phase 4 Studieshttps://modernaesthetics.com/news/restylane-refyne-and-restylane-defyne-show-lasting-natural-benefit-in-phase-4-studies/2472251/Two Phase 4 clinical studies of Restylane® Refyne and Restylane® Defyne show that the natural-looking results last. Specifically, the Natural Expression study found that naturalness in facial expressions was at least main
- Breaking Business News: Apax Partners to Acquire Syneronhttps://modernaesthetics.com/news/breaking-business-news-apax-partner-to-acquire-syneron/2472253/An affiliate of funds advised by Apax Partners will acquire all of the outstanding shares of Syneron Candela for $11.00 per share in cash in a transaction valued at approximately $397 million. The per share acquisition price represe
- Survey: Many Bothered By Double Chins, Take Steps To Cover Uphttps://modernaesthetics.com/news/survey-many-bothered-by-double-chins-take-steps-to-cover-up/2472259/Close to 50 percent of individuals are bothered by the appearance of the area under their chin, and many alter their behavior as a result, according to a new survey commissioned by Allergan plc.<